arabinofuranosylcytosine triphosphate has been researched along with fludarabine phosphate in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avramis, VI; Champagne, J; Ettinger, LJ; Finkelstein, J; Hammond, GD; Holcenberg, JS; Krailo, M; Poplack, DG; Reaman, G; Sato, J | 1 |
| Catapano, CV; Chandler, KB; Fernandes, DJ | 1 |
| Cabanillas, F; Danhauser, L; Keating, M; Plunkett, W | 1 |
| Gandhi, V; Keating, MJ; Nowak, B; Plunkett, W | 1 |
1 trial(s) available for arabinofuranosylcytosine triphosphate and fludarabine phosphate
| Article | Year |
|---|---|
Pharmacology of fludarabine phosphate after a phase I/II trial by a loading bolus and continuous infusion in pediatric patients.
Topics: Antimetabolites, Antineoplastic; Arabinofuranosylcytosine Triphosphate; Child, Preschool; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Vidarabine Phosphate | 1990 |
3 other study(ies) available for arabinofuranosylcytosine triphosphate and fludarabine phosphate
| Article | Year |
|---|---|
Inhibition of primer RNA formation in CCRF-CEM leukemia cells by fludarabine triphosphate.
Topics: Aphidicolin; Arabinofuranosylcytosine Triphosphate; Deoxyguanine Nucleotides; Diterpenes; DNA Primase; DNA-Directed DNA Polymerase; DNA, Neoplasm; Humans; Leukemia; RNA; RNA Nucleotidyltransferases; Tumor Cells, Cultured; Vidarabine Phosphate | 1991 |
9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate pharmacokinetics in plasma and tumor cells of patients with relapsed leukemia and lymphoma.
Topics: Antimetabolites, Antineoplastic; Arabinofuranosylcytosine Triphosphate; Arabinonucleotides; DNA; Humans; Kinetics; Leukemia; Lymphoma; Vidarabine Phosphate | 1986 |
Modulation of arabinosylcytosine metabolism by arabinosyl-2-fluoroadenine in lymphocytes from patients with chronic lymphocytic leukemia: implications for combination therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Arabinofuranosylcytosine Triphosphate; Arabinonucleotides; Cytarabine; Drug Evaluation; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocytes; Vidarabine Phosphate | 1989 |